Biotechnology, economics, and the business of blood.
Carter
T H
TH
D001709:Biotechnology; D001771:Blood Banks / Q000191:economics / Q000458:organization & administration / Q000706:statistics & numerical data / Q000600:supply & distribution; D001781:Blood Component Removal / Q000191:economics / Q000379:methods; D016913:Blood Component Transfusion / Q000191:economics / Q000379:methods; D001782:Blood Donors; D001802:Blood Substitutes; D001803:Blood Transfusion / Q000191:economics / Q000379:methods / Q000706:statistics & numerical data; D001804:Blood Transfusion, Autologous / Q000379:methods; D003365:Costs and Cost Analysis; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000494:pharmacology; D005060:Europe; D005818:Genetic Engineering; D006801:Humans; D007564:Japan; D010949:Plasma; D012011:Red Cross; D014481:United States
D001802:Blood Substitutes; D004921:Erythropoietin